6
Oct
2026

INGREDIA SA

Exhibitor at CPHI Milan 2026 stand 16C75, Finished Dosage & Formulation
About Us

Dairy explorers since 1949, Ingredia is a French dairy cooperative which develops and manufactures innovative ingredients: functional & nutritional milk proteins, dairy powders and natural bioactive ingredients - for the worldwide Health, Nutrition and Food industries.
Through strong links with its customers, Ingredia is constantly innovating for the products of tomorrow. Oriented in a sustainable production, Ingredia works to feed and protect better.

  • Country/Region:
    France
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
Other
Primary activities
API Producer
Ingredients Distributor/Buyer
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 16C75, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Xelflex

    Product Xelflex

    Xelflex® is a milk protein hydrolysate with an anti-inflammatory effect. Several studies showed that consumption of dairy products was associated with lower low-grade systemic inflammation. Xelflex®, has a proven efficacy in reducing inflammatory markers and oedema. Xelflex benefits from a consumer study s...
  • Lactium®

    Product Lactium®

    In a world where professional and personal demands are increasing, stress has become an omnipresent phenomenon with a profound impact on physical and mental health. When stress becomes chronic, it not only disrupts emotions and mood, but also affects the ability to sleep well.

    Finding effectiv...
  • Pep2Dia®

    Product Pep2Dia®

    For 59% of global consumers*, being in good health is being fit and active. It is also, for 45% of them, to show a healthy waistline. For those, blood sugar management has been a trending topic. Blood sugar management product launches have grown by +113% over the past 5 years**.

    Long know...

INGREDIA Resources (1)

  • Video Xelflex®, a bioactive ingredient with joint health benefits

    Osteoarthritis is a very common disease, leading to chronic pain, loss of joint function, and reduced mobility: 33 to 50% of people over 65 are affected by mobility loss (Mobility : Harvard Health Publishing®, 2022.) 

    Xelflex® is a milk protein hydrolysate with anti-inflammatory effect.


    Xelflex® benefits from a consumer study showing significant results on pain reduction, improvement of mobility and quality of life.